1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Germany >
  5. Frontier Biosolutions Acquires Coriolis Pharma

M&A Deal Summary

Frontier Biosolutions Acquires Coriolis Pharma

On October 16, 2023, Frontier Biosolutions acquired life science company Coriolis Pharma

Acquisition Highlights
  • This is Frontier Biosolutions’ 1st transaction in the Life Science sector.
  • This is Frontier Biosolutions’ 1st transaction in Germany.

M&A Deal Summary
Date 2023-10-16
Target Coriolis Pharma
Sector Life Science
Buyer(s) Frontier Biosolutions
Deal Type Add-on Acquisition

Target

Coriolis Pharma

Martinsried, Germany
Coriolis Pharma provides formulation research and development, analytical services and non-GMP manufacturing of innovative high-value biologics and cell and gene therapy products. Coriolis Pharma is based in Martinsried, Germany.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Frontier Biosolutions

New York, New York, United States
Category Company
Sector Life Science
DESCRIPTION

Frontier Biosolutions is a global pharma services platform. Frontier Biosolutions is based in New York.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: Germany M&A 1 of 1
Year: 2023 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal